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Introduction
Reorganization of epithelial sheets plays a crucial role in the
formation of various luminal organs in metazoans (Lubarsky and
Krasnow, 2003; Schock and Perrimon, 2002). Epithelial
morphogenesis is a highly complex process involving cell division,
migration, cell-cell and cell–extracellular-matrix adhesions, cell
shape changes, and apoptosis (O’Brien et al., 2002; Schock and
Perrimon, 2002). This process can be modeled in vitro by embedding
epithelial cells into three-dimensional (3D) gels of either individual
(collagen) or mixed (Matrigel) extracellular matrix proteins
(O’Brien et al., 2002; Schmeichel and Bissell, 2003; Walpita and
Hay, 2002). In such 3D matrices, colonies of cultured epithelial
cells undergo a multistep reorganization from an amorphous
aggregate to a spherical cyst, which can be further transformed into
linear or branched tubes by stimulation with growth factors (O’Brien
et al., 2002).
The formation of cysts is considered to be a crucial step in
epithelial morphogenesis in vitro (Lubarsky and Krasnow, 2003;
O’Brien et al., 2002). Such cysts represent hollow spheres comprised
of monolayers of epithelial cells and they recapitulate a variety of
spherical structures (acini, alveoli, follicles) that are formed by
epithelial sheets in vivo. Within a cyst, epithelial cells are connected
to each other by typical intercellular junctions and are polarized in
such a manner that the apical surface of all cells is oriented towards
the lumen of the cyst (Lubarsky and Krasnow, 2003; O’Brien et
al., 2002). The general architecture of epithelial cysts, specifically
the spherical shape and the apico-basal polarization of cell
components, strongly suggests that the actin cytoskeleton is involved
in the formation and/or maintenance of normal cyst morphology.
Indeed, two lines of evidence demonstrate the role of actin filaments
in cyst biogenesis. First, disruption of the actin cytoskeleton by
cytochalasin D treatment has been reported to prevent the formation
of lumen-bearing cysts of cultured rat intestinal epithelial cells
(Olson et al., 1991) and human colon carcinoma cells (Lincz et al.,
1997). Second, expression of dominant-negative mutants or siRNA-
mediated knockdown of major regulators of F-actin organization,
Rac1 and Cdc42, have been shown to invert cell polarity in kidney
epithelial cysts (Martin-Belmonte et al., 2007; O’Brien et al., 2001).
Despite these reports, the role of the actin cytoskeleton in epithelial
cystogenesis, and the mechanisms by which F-actin reorganization
influences the formation and maintenance of cyst architecture
remain poorly understood.
Organization of intracellular F-actin depends on a large family
of myosin motor proteins (Cramer, 1999; Maciver, 1996; O’Connell
et al., 2007). By hydrolyzing ATP, myosins generate mechanical
force to move and bundle actin microfilaments, thereby regulating
the architecture and dynamic reorganization of the actin cytoskeleton
(De La Cruz and Ostap, 2004; O’Connell et al., 2007). Conventional
myosin II is a major protein that drives muscle contraction and is
a crucial regulator of motility, cell shape and cytokinesis in non-
muscle cells (Cramer, 1999; Maciver, 1996). Several recent studies
have implicated myosin II in the regulation of epithelial
morphogenesis. For example, this motor protein was found to be
important for the formation of intercellular junctions and the
The development of luminal organs begins with the formation
of spherical cysts composed of a single layer of epithelial cells.
Using a model three-dimensional cell culture, this study
examines the role of a cytoskeletal motor, myosin II, in cyst
formation. Caco-2 and SK-CO15 intestinal epithelial cells were
embedded into Matrigel, and myosin II was inhibited by
blebbistatin or siRNA-mediated knockdown. Whereas control
cells formed spherical cysts with a smooth surface, inhibition
of myosin II induced the outgrowth of F-actin-rich surface
protrusions. The development of these protrusions was
abrogated after inhibition of F-actin polymerization or of
phospholipase C (PLC) activity, as well as after overexpression
of a dominant-negative ADF/cofilin. Surface protrusions were
enriched in microtubules and their formation was prevented
by microtubule depolymerization. Myosin II inhibition caused
a loss of peripheral F-actin bundles and a submembranous
extension of cortical microtubules. Our findings suggest that
inhibition of myosin II eliminates the cortical F-actin barrier,
allowing microtubules to reach and activate PLC at the plasma
membrane. PLC-dependent stimulation of ADF/cofilin creates
actin-filament barbed ends and promotes the outgrowth of
F-actin-rich protrusions. We conclude that myosin II regulates
the spherical shape of epithelial cysts by controlling actin
polymerization at the cyst surface.
Supplementary material available online at
http://jcs.biologists.org/cgi/content/full/121/11/1803/DC1
Key words: Actin polymerization, phospholipase C, ADF/cofilin,
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establishment of apico-basal polarity of epithelial cells growing in
two-dimensional (2D) monolayers (Ivanov et al., 2005; Zhang et
al., 2005). Furthermore, myosin II was shown to drive reorganization
of epithelial layers at early stages of embryogenesis in Drosophila
and zebrafish (Jacinto et al., 2002; Koppen et al., 2006). Finally,
recent studies have implicated Rho-dependent kinase in the
development of mammalian lung and kidney (Meyer et al., 2006;
Moore et al., 2005; Rogers et al., 2003), thereby suggesting a role
of myosin II, which is a major downstream effector of Rho-kinase.
However, direct evidence of myosin II involvement and the
molecular mechanisms by which this motor protein can drive
mammalian epithelial morphogenesis are still lacking. The present
study was designed to investigate the role of nonmuscle myosin
(NMM)II in the formation of 3D intestinal epithelial cysts using an
in vitro model: human intestinal epithelial cells grown in a Matrigel
matrix.
Results
To investigate the role of myosin II in epithelial morphogenesis,
we first analyzed the localization of myosin II in epithelial cysts.
Caco-2 cells were embedded in 3D Matrigel, and 72 hours later
were fixed and double-labeled for F-actin and either NMMII heavy
chain isoform A or isoform B. These NMMII isoforms have been
shown to be important for cell and tissue morphogenesis (Brown
and Bridgman, 2004; Conti et al., 2004), and to be abundantly
expressed in human colonic epithelial cells (Ivanov et al., 2007).
As shown in Fig. 1, Matrigel-embedded Caco-2 cells formed
spherical cysts with well-developed central lumens. Both NMMIIA
and NMMIIB were especially enriched in F-actin bundles that line
the basal surface of the cyst (arrows). To gain insight into the
functional role of myosin II, we inhibited its activity using S(–)-
blebbistatin (Straight et al., 2003) or Y-27632 (Hirose et al., 1998)
and examined the effects of this inhibition on the formation of 3D
cysts. Blebbistatin and Y-27632 are known to affect NMMII via
different mechanisms, with the former blocking the ATPase activity
of myosin heavy chain (Kovacs et al., 2004; Straight et al., 2003)
and the latter preventing activatory phosphorylation of myosin light
chain (Hirose et al., 1998). Initially, S(–)-blebbistatin (100 µM), Y-
27632 (20 µM) or vehicle were added at the time of embedding of
Caco-2 cells into 3D Matrigel and, 72 hours later, cyst morphology
was visualized by labeling for F-actin. Whereas vehicle-treated cells
formed cysts with smooth surfaces and central lumens (Fig. 2A),
cysts developing in the presence of myosin II inhibitors displayed
distinct abnormalities. The most obvious abnormality was the
presence of F-actin-rich surface protrusions (Fig. 2A, arrows), which
were observed in 78±8% of blebbistatin-treated and 69±7% of Y-
27632-treated cysts.
We next investigated whether the formation of peripheral F-actin-
rich spikes was associated with dynamic reorganization of 3D cell
aggregates during cyst formation, or whether these spikes could
also originate from fully differentiated epithelial cells. Preformed
Caco-2 epithelial cysts cultured for 72 hours in 3D Matrigel were
incubated for an additional 12 hours in the presence of either 100
µM blebbistatin or vehicle. In preformed cysts, inhibition of myosin
Journal of Cell Science 121 (11)
Fig. 1. Myosin II is enriched at the surface of 3D epithelial cysts. Caco-2 cells
were embedded in Matrigel for 72 hours, fixed, and fluorescently double-labeled
for F-actin (red) and either NMMIIA or NMMIIB (green). Cross-sections of
Caco-2 cysts show that significant pools of NMMIIA and NMMIIB accumulate
within F-actin bundles at the cyst surface (arrows). Scale bar: 20 µm.
Fig. 2. Inhibition of myosin II causes the formation of F-actin-rich
protrusions at the surface of epithelial cysts. (A,B) Caco-2 (A) or SK-CO15
(B) cells were embedded for 72 hours into 3D Matrigel in the presence of
either vehicle or the myosin II inhibitors blebbistatin (100 µM) or Y27632
(20 µM) and analyzed for cyst morphology by fluorescent labeling for
F-actin. Vehicle-treated Caco-2 and SK-CO15 cells formed spherical cysts
with smooth surfaces, whereas cysts grown in the presence of myosin II
inhibitors developed radiating F-actin protrusions (arrows). (C,D) SK-CO15
cells were transfected with either control or NMMIIA-specific siRNA and,
72 hours later, were analyzed for NMMIIA expression (C) and morphology of
3D cysts (D). NMMIIA knockdown caused a significant decrease in the level
of NMMIIA and induced the formation of numerous F-actin-rich surface
spikes. *P<0.05. 
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1805Myosin II and epithelial cystogenesis
II triggered the formation of peripheral protrusions (Fig. 3A) that
were undistinguishable from those caused by addition of blebbistatin
at the onset of cystogenesis (Fig. 2A). This suggests that the
formation of surface spikes reflects changes in the shape of
stationary epithelial cells. Given these findings, in subsequent
experiments surface spikes were induced by 12 hours of treatment
of preformed cysts with blebbistatin.
To ensure that myosin-II-dependent formation of peripheral
protrusions does not represent a peculiarity of the Caco-2 cell line,
effects of NMMII inhibition were investigated in another human
colonic epithelial cell line, SK-CO15 (Ivanov et al., 2006; Le Bivic
et al., 1989). Similarly to Caco-2 cells, SK-CO15 cells grow as
spherical cysts in 3D Matrigel (Fig. 2B). Furthermore, blebbistatin
treatment induced the formation of peripheral protrusions in 93±3%
of SK-CO15 cysts, which was significantly higher than the
2.0±0.6% of protrusive cysts found in a vehicle-treated group. To
verify that the development of surface protrusions following
blebbistatin treatment is not caused by unrelated side effects of this
myosin II inhibitor, we examined the effects of siRNA-mediated
downregulation of NMMIIA, which was previously shown to alter
the shape of individual epithelial cells grown on a 2D surface
(Ivanov et al., 2007). SK-CO15 cells transfected with NMMIIA-
specific or control siRNAs were embedded into 3D Matrigel, and
cyst morphology was analyzed by F-actin labeling and confocal
microscopy. As shown in Fig. 2C, transfection with NMMIIA-
specific siRNA caused significant (~70%) downregulation of
myosin IIA expression in SK-CO15 cells. Consistent with the
inhibitor studies, this knockdown induced the formation of
peripheral protrusions in 50±5% of SK-CO15 cysts, which was
significantly higher than the 1.7±0.6% of protrusive cysts observed
in the control siRNA-transfected group (Fig. 2D). Overall, this
pharmacological and siRNA-knockdown data suggest that the
formation of surface protrusions in 3D intestinal epithelial cysts is
a common and direct consequence of myosin II inhibition.
A reasonable hypothesis for these findings is that outgrowth of
peripheral F-actin-rich protrusions in stationary epithelial cells is
driven by actin polymerization. To test this possibility, we used a
pharmacological inhibitor of actin polymerization, latrunculin B.
Latrunculins bind to monomeric actin and prevent its incorporation
into actin filaments, thus causing depolymerization of dynamic,
constantly turning-over filaments (Morton et al., 2000). As shown
in Fig. 3A, latrunculin B (1 µM) dramatically decreased the number
of spike-bearing Caco-2 cysts from 95±2% in the blebbistatin-only
group to 0% in groups treated with the combination of blebbistatin
and the F-actin-depolymerizing drug. This finding indicates a key
role for actin polymerization in the formation of blebbistatin-induced
surface protrusions.
Myosin II is known to promote cortical F-actin dynamics by
mechanisms that involve either submembrane flux of actin
filaments, known as ‘cortical flow’ (Mandato et al., 2000), or actin-
filament severing and/or depolymerization (Guha et al., 2005;
Medeiros et al., 2006). Because inhibition of myosin II is likely to
result in decreased dynamics of cortical F-actin, we next investigated
whether such F-actin stabilization could recapitulate the formation
of surface protrusions in epithelial cysts. The dynamics of cortical
actin was decreased by either inhibiting cortical flow with tetravalent
lectins, such as wheat germ agglutinin [WGA (Canman and Bement,
1997; Rosenblatt et al., 2004)] or by suppressing depolymerization
of actin filaments with a cell-permeable drug, jasplakinolide (Bubb
et al., 1994). Incubation of Caco-2 cysts for 12 hours with either
WGA (500 µg/ml) or jasplakinolide (0.5 µM) did not induce
peripheral spikes (Fig. 3B). These results indicate that inhibition
of myosin II triggers the formation of surface protrusions by
activating signaling pathways to promote actin polymerization and
not by decreasing the dynamics of cortical F-actin.
Members of the Rho family of small GTPases, such as Rac1 and
Cdc42, are considered as crucial activators of actin polymerization,
which drives cell motility and a variety of other cellular processes
(Millard et al., 2004; Takenawa and Suetsugu, 2007). We therefore
investigated whether Rac1 and Cdc42 play a role in the formation
of F-actin-rich protrusions in blebbistatin-treated cysts. For these
experiments, we used approaches that included pharmacological
inhibitors, expression of dominant-negative mutants and GTPase-
activation assays. As shown in Fig. 4A, pharmacological inhibition
of Rac with NSC 23766 (100 µM) (Gao et al., 2004) or of Cdc42
with secramine A (20 µM) (Pelish et al., 2006) failed to prevent
the formation of blebbistatin-induced surface protrusions in Caco-
2 cysts. It is noteworthy that the same concentrations of NSC 23766
and secramine A significantly inhibited motility of Caco-2 cells in
a wound-closure model (data not shown), thus confirming the
activity of these compounds. Our pharmacological inhibition studies
were complemented with the use of Rac1 and Cdc42 dominant-
negative mutant constructs expressed in the adenoviral vector. Due
Fig. 3. Formation of peripheral protrusions is mediated by actin
polymerization and is not caused by stabilization of cortical F-actin.
(A) Preformed Caco-2 cysts were treated for 12 hours with either blebbistatin
alone (100 µM) or with a combination of blebbistatin and latrunculin B (1 µM)
to inhibit actin polymerization. Inhibition of actin polymerization prevented
the formation of peripheral protrusions in blebbistatin-treated Caco-2 cysts
(*P<0.001). (B) Preformed Caco-2 cysts were treated for 12 hours with either
vehicle, a cortical flow inhibitor (WGA; 500 µg/ml) or an F-actin-stabilizing
drug (jasplakinolide; 0.5 µM). The formation of protrusions on the cyst surface
was not induced by any treatment. 
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to difficulties in obtaining sufficient numbers of 3D Caco-2 cysts
after infection with dominant-negative Rac1 or Cdc42 adenoviruses,
this experiment was performed with cells cultured on Matrigel-
coated coverslips. Caco-2 cells plated at low density on Matrigel-
coated coverslips did not extensively spread but formed compact
spheroid colonies (supplementary material Fig. S1). Analogous to
the effects observed on 3D cysts, blebbistatin treatment of 2D Caco-
2 colonies induced the formation of multiple peripheral protrusions
(Fig. 4B). However, cells infected with dominant-negative Rac1-
and Cdc42-bearing adenoviruses developed peripheral protrusions
upon blebbistatin treatment similarly to cells infected with control
EGFP-containing adenovirus (Fig. 4B, arrows). Lastly, we
investigated whether blebbistatin activates Rac1 and Cdc42. Caco-
2 colonies growing on 2D Matrigel were treated for 12 hours with
either blebbistatin or vehicle, and the levels of activated Rac1 and
Cdc42 in cell lysates was determined using the PAK1-GST binding
assay. As shown in Fig. 4C, blebbistatin treatment did not increase
the levels of active Rac1 and Cdc42.
Because Cdc42 and Rac1 promote actin polymerization by
activating their down-stream effectors – a neuronal Wiskott-Aldrich
syndrome protein (N-WASP) and members of the WASP family
verprolin-homologous (WAVE) proteins, respectively – we next
investigated whether N-WASP and WAVE1 mediate the formation
of peripheral protrusions in myosin-II-inhibited epithelial cysts. We
performed siRNA-mediated knockdown of N-WASP and WAVE1
in SK-CO15 cells and analyzed its effect on spike formation. We
observed that neither protein knockdown prevented the development
of peripheral protrusions in blebbistatin-treated cysts (data not
shown). Together, these data suggest that Rac1-WAVE1-mediated
and Cdc42–N-WASP-mediated signaling are not involved in the
formation of surface spikes in intestinal epithelial cysts induced by
myosin II inhibition.
Blebbistatin-induced protrusions on epithelial cysts appeared to
be morphologically similar to F-actin-rich neurites observed in
stimulated neuronal and neuroendocrine cells. Neurite outgrowth
was shown to be dependent on actin polymerization and its
upstream signaling events have been extensively characterized
(Govek et al., 2005; Sarmiere and Bamburg, 2004; Scott and Luo,
2001). Therefore, to determine the signaling pathway(s) that
contribute to the formation of blebbistatin-induced spikes, we
analyzed the role of signaling molecules implicated in neurite
outgrowth (Gu et al., 2005; Hall et al., 1996; Motegi et al., 2004;
Tornieri et al., 2006; Xie et al., 2006). Comprehensive
pharmacological screens did not show any effect of inhibitors of
tyrosine kinases (genistein, 50 µM; herbimycin A,
2 µM; PP2, 10 µM), mitogen-activated protein
kinases (PD 98059, 10 µM; U0126, 5 µM; ERK II
inhibitor, 20 µM; SP 600125, 20 µM) or
phosphatidylinositol-3 kinase (LY 294002; 20 µM)
on the genesis of spikes in blebbistatin-treated
Caco-2 cysts (data not shown). However,
inhibition of phospholipase C (PLC) with
either 1-O-Octadecyl-2-O-methyl-sn-glycero-3-
phosphorylcholine (ET-18-OCH3, 10 µM) (Powis
et al., 1992) or U-73122 (1 µM) (Bleasdale et al.,
1990) dramatically attenuated the development of
peripheral protrusions. As shown in Fig. 5,
pharmacological inhibition of PLC significantly
decreased the number of spike-bearing cysts from
93±3% in the blebbistatin-only group to 1±1% and
12±1% in cells exposed to ET-18-OCH3 or U-
73122, respectively. Importantly, U-73122 also
inhibited development of peripheral protrusions
induced by siRNA-mediated depletion of NMMIIA
Journal of Cell Science 121 (11)
Fig. 4. Activity of Rac1 and Cdc42 is not required for the
formation of blebbistatin-induced protrusions. (A) Caco-2
cysts were treated for 12 hours with either blebbistatin alone
or in a combination with the Rac inhibitor NSC 23766
(100 µM) or the Cdc42 inhibitor secramine A (20 µM).
Pharmacological inhibition of Rac and Cdc42 did not
prevent the development of blebbistatin-induced spikes.
(B) Caco-2 cells growing on Matrigel-coated coverslips
were infected with adenoviruses bearing either control
EGFP, or EGFP-tagged dominant-negative N17Rac1 or
N17Cdc42 and treated for 12 hours with blebbistatin
(100 µM). Cells infected either with control virus or with
dominant-negative Rac1 or Cdc42 mutants developed
peripheral protrusions upon inhibition of myosin II
(arrows). (C) Caco-2 cells were treated for 12 hours with
either blebbistatin (100 µM) or vehicle, and activation
statuses of Rac1 and Cdc42 were determined in cell lysates
using pull-down assays. No increase in the levels of
activated Rac1 or Cdc42 were observed in blebbistatin-
treated cells.
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in SK-CO15 cysts (supplementary material Fig. S2). ET-18-OCH3
and U-73122 are general PLC inhibitors, blocking the activity of
several isoforms of this enzyme. However, the PLCγ1 and PLCβ2
isoforms are likely to be important for the spike formation because
of their involvement in the F-actin-remodeling and F-actin-
dependent processes (Brugnoli et al., 2007; Lian et al., 2005;
Mouneimne et al., 2004; Yin and Janmey, 2003). To test this
hypothesis, we performed a dual siRNA-mediated knockdown of
PLCγ1 and PLCβ2 in SK-CO15 cells. Downregulation of both PLC
isoforms (Fig. 6A) did not alter the morphology of control SK-
CO15 cysts (data not shown), but significantly decreased the number
of spike-bearing cysts after blebbistatin treatment, from 84±3% in
the control siRNA-treated group to 25±5% in the PLC-isoforms-
depleted group (Fig. 6B,C). Interestingly, individual knockdown of
either PLCγ1 or PLCβ2 did not affect spike formation (data not
shown), which is likely to reflect a functional redundancy of
different PLC isoforms.
We also investigated whether blebbistatin influences the
intracellular distribution of PLCγ1, which is important for regulating
the local activity of this enzyme on cellular membranes.
Immunofluorescence labeling and confocal microscopy revealed the
accumulation of PLCγ1 as well as active Ser1248/1249-
phosphorylated PLCγ1 (Dittmar et al., 2002; Kim et al., 1991) in
the surface protrusions of blebbistatin-treated 3D cysts (Fig. 7A).
However, blebbistatin treatment did not affect expression levels of
two active forms of PLCγ1 phosphorylated at Tyr783 and
Ser1248/1249 in Caco-2 cells (data not shown). These results
suggest that myosin II does not modulate phosphorylation-
dependent activation of this enzyme. Furthermore, biochemical
fractionation of Caco-2 cells detected a significant increase in the
amount of membrane-bound PLCγ1 after inhibition of myosin II
(Fig. 7B); this might represent an alternative mechanism of PLC
activation. Overall, these results highlight a crucial role of PLC
activity in the development of F-actin-rich peripheral protrusions
induced by myosin II inhibition in intestinal epithelial cysts.
A mechanistic link between PLC activity and reorganizations of
the F-actin cytoskeleton is likely to involve PLC-dependent
activation of actin-depolymerizing factor (ADF)/cofilin proteins,
which are known for their ability to depolymerize and sever actin
filaments (Bamburg, 1999; Ono, 2007). Particularly, ADF/cofilin-
mediated severing was shown to increase the amount of free actin-
filament barbed ends and thus to promote filament polymerization
and growth (Wang et al., 2007). Based on these data, we next
investigated whether ADF/cofilin proteins play a role in the
formation of blebbistatin-induced spikes. Caco-2 cells were
embedded for 72 hours into 3D Matrigel in the presence of
adenoviruses containing either an EGFP-tagged constitutively
inactive S3E cofilin mutant (Suurna et al., 2006) or control EGFP
and, 72 hours later, were treated with blebbistatin. Thereafter, cysts
were labeled for F-actin and their surface morphology was examined
by confocal microscopy. As shown in Fig. 8, overexpression of
inactive cofilin significantly decreased the number of spike-bearing
cysts from 89±2% in the control EGFP-expressing group to 6±3%
in cells expressing the inactive cofilin mutant. Interestingly,
overexpression of a constitutively active S3A cofilin mutant induced
formation of peripheral processes in control Caco-2 cysts even
without myosin II inhibition (Fig. 8C). However, these processes
appeared as surface blebs rather than as the linear radial spikes
observed in myosin-II-inhibited cysts. Two major conclusions can
be made from this observation. One is that ADF/cofilin is involved
in the formation of peripheral F-actin-rich spikes by increasing
protrusive dynamics of the cyst surface. Another conclusion is that
ADF/cofilin activation is not sufficient to mediate spike formation
Fig. 5. PLC activity is required for the formation of peripheral protrusions in
epithelial cysts. Caco-2 cysts were treated for 12 hours with either blebbistatin
alone or in combination with the PLC inhibitors ET-18-OCH3 (10 µM) or
U-73122 (1 µM). Both pharmacological inhibitors of PLC significantly
attenuated the formation of blebbistatin-induced spikes (*P<0.001). 
Fig. 6. PLCγ1 and PLCβ2 isoforms mediate the formation of peripheral
protrusions in epithelial cysts. SK-CO15 cells were transfected with either
control siRNA or a combination of PLCγ1- and PLCβ2-specific siRNAs,
embedded into 3D Matrigel and, 72 hours later, were treated with blebbistatin.
Dual PLCγ1/PLCβ2 knockdown caused a dramatic decrease in the level of
both PLC isoforms (A) and significantly attenuated the formation of F-actin-
rich spikes on the cyst surface (B,C) (*P<0.01). 
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in myosin-II-inhibited epithelial cysts and that an additional
mechanism is required to transform cofilin-dependent peripheral
membrane processes into linear spikes.
To identify this additional mechanism, we investigated the role
of microtubules. Our focus on these cytoskeletal structures was
based on recent evidence that microtubules regulate the activity and
intracellular distribution of PLCγ1 (Chang et al., 2005; Itoh et al.,
1996; Ramoni et al., 2001) and that they play a crucial role in
neurite outgrowth (Gordon-Weeks, 2004). Microtubules were
depolymerized in myosin-II-inhibited Caco-2 cysts by either
nocodazole (30 µM) or vinblastin (10 µM) treatment. This
microtubule depolymerization dramatically decreased the amount
of protrusion-bearing cysts from 86±2% in the blebbistatin-only
group to 5±1% and 7±2% in experimental groups exposed to
nocodazole and vinblastin. respectively (Fig. 9A). Likewise,
vinblastin treatment significantly inhibited the formation of
peripheral spikes in SK-CO15 cysts induced by siRNA-mediated
downregulation of NMMIIA (supplementary material Fig. S2).
Furthermore, immunofluorescence analysis of blebbistatin-treated
Caco-2 cysts revealed thick microtubule bundles in the proximal
zone of surface protrusions (Fig. 9B, arrows), whereas the distal
ends of protrusions were composed predominantly of F-actin.
Microtubule reorganization in living cells is regulated by the
Journal of Cell Science 121 (11)
Fig. 7. PLC is localized in surface protrusions
and becomes redistributed to a membrane-bound
fraction of blebbistatin-treated epithelial cells.
(A) Caco-2 cells growing for 72 hours on
Matrigel-coated coverslips were treated for 12
hours with blebbistatin (100 µM), fixed, and
double-labeled for F-actin (green) and either total
or active Ser1248/1249-phosphorylated PLCγ1
(red). Both total and active PLCγ1 localize within
blebbistatin-induced F-actin-rich protrusions
(arrows). (B) Caco-2 cells were treated with
either blebbistatin or vehicle, and the amounts of
membrane-bound and cytosolic PLCγ1 were
determined by cell fractionation and western
blotting. A significant increase in the amount of
membrane-bound PLCγ1 was observed after
myosin II inhibition (*P<0.05).
Fig. 8. Cofilin activity is required for the development of surface protrusions
in blebbistatin-treated cysts. Caco-2 cells were embedded for 72 hours into 3D
Matrigel in the presence of adenoviruses bearing either control EGFP (A) or an
EGFP-tagged inactive S3E cofilin mutant (B), followed by 12 hours of
treatment with blebbistatin. Inhibition of cofilin activity significantly
attenuated the formation of blebbistatin-induced surface protrusions (D)
(*P<0.01). (C) Caco-2 cells were grown in 3D Matrigel in the presence of
adenoviruses bearing an EGFP-tagged constitutively active S3A cofilin
mutant. Overexpression of active cofilin induced the formation of F-actin-rich
processes on the cyst surface. 
Fig. 9. Microtubules are involved in the formation of blebbistatin-induced
protrusions. (A) Preformed Caco-2 cysts were treated for 12 hours with either
blebbistatin alone or in combination with the microtubule-depolymerizing
drugs nocodazole (30 µM) or vinblastin (10 µM). Microtubule
depolymerization prevented the formation of blebbistatin-induced protrusions
(*P<0.01). (B) Caco-2 cysts were treated for 12 hours with blebbistatin, fixed,
and double-labeled for F-actin (green) and the microtubule marker α-tubulin
(red). Microtubules are enriched in the base of blebbistatin-induced spikes
(arrows).
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dynamic cycle of microtubule extension and shrinkage at their plus
ends (Howard and Hyman, 2003). Therefore, we also analyzed
whether microtubule plus-end dynamics is important for the
formation of F-actin-rich surface protrusions by selectively blocking
such dynamics with a low concentration (100 nM) of nocodazole.
We observed that this concentration of nocodazole dramatically
decreased the number of spike-bearing Caco-2 cysts (from 98% to
7%) caused by blebbistatin treatment (supplementary material Fig.
S3).
To gain more insight into the relationships of actin filaments and
microtubules after myosin II inhibition, we examined the
organization of these cytoskeletal structures in Caco-2 cells cultured
on Matrigel-coated coverslips. Double-fluorescence labeling
revealed that control cells possessed thick F-actin bundles oriented
parallel to the edge of epithelial colonies (Fig. 10A). A dense
network of microtubules was localized immediately subjacent to
the F-actin bundles (Fig. 10A, arrows). Relatively few parallel-
aligned microtubules were detected in the immediate vicinity of the
plasma membrane. Inhibition of myosin II was associated with two
major changes in the organization of the cortical cytoskeleton. The
first was the disappearance of cortical F-actin bundles, which were
replaced by a disorganized F-actin network. The second change was
the reorientation of microtubules so that they became perpendicular
to cell-spreading edges, and their extension into the submembranous
compartment (Fig. 10A, arrowheads). We quantified these changes
in cortical microtubule distribution by comparing the pixel intensity
ratio for the α-tubulin signal at the front versus the back of parallel
F-actin bundles in control Caco-2 colonies with the α-tubulin
intensity ratio in the distal versus the proximal parts of blebbistatin-
induced protrusions. As shown in Fig. 10B, such a tubulin intensity
ratio was significantly higher in blebbistatin-induced protrusions,
which indicates the enrichment of microtubules in the
submembranous space. Furthermore, microtubules in blebbistatin-
treated cells appeared to be thicker compared with vehicle-treated
controls, suggesting increased stability. This suggestion was
supported by Triton X-100 (TX-100) fractionation, which
demonstrated a significant increase in the amount of TX-100-
insoluble, stable microtubules in blebbistatin-treated Caco-2 cells
(supplementary material Fig. S4). Overall, our results show that
interplay between microtubules and the F-actin cytoskeleton plays
a crucial role in the formation of peripheral protrusions following
inhibition of myosin II in intestinal epithelial cells.
Discussion
The formation of spherical cysts represents a crucial early step in
3D epithelial morphogenesis. Cysts later transform into tubules that
elongate and branch, leading to the development of luminal organs
in the body. Studies of model epithelial cysts formed in 3D protein
matrices in vitro show that the transformation from a cyst to a tubule
involves a directional outgrowth of surface protrusions governed
by a gradient of morphogenic factors or other extrinsic cues
(O’Brien et al., 2002; Rogers et al., 2003). It is therefore likely that
outgrowth of these peripheral spikes is temporally and spatially
controlled. Conversely, unregulated protrusiveness at a cyst surface
might lead to misshaped tubules and thus to abnormal
organogenesis.
In this study, we describe a novel mechanism limiting the
outgrowth of peripheral protrusions in 3D intestinal epithelial cysts
that involves activity of the major F-actin motor, myosin II. Our
data demonstrate the enrichment of myosin II in F-actin bundles
that line the basal surface of cysts (Fig. 1). Moreover,
pharmacological inhibition or expressional downregulation of
myosin II induced the formation of radiating F-actin-rich protrusions
on the cyst surface (Fig. 2). This effect of myosin II inhibition has
not been previously reported for 3D epithelial cystogenesis.
Although acquisition of a protrusive phenotype upon interfering
with the functions of myosin II has been observed in individual
epithelial and fibroblastic cells in 2D cultures (Even-Ram et al.,
2007; Scaife et al., 2003), the mechanisms underlying the formation
of these protrusions and development of spikes in 3D cysts are likely
to be different. Protrusions induced by inhibition of myosin IIA in
individual fibroblasts can occur secondary to attenuated retraction
of the cell rear in motile cells (Even-Ram et al., 2007). This
retraction mechanism is not plausible in stationary epithelial cells
within 3D cysts, in which the formation of peripheral protrusions
depends on actin polymerization (Fig. 3A). Interestingly, our
pharmacological inhibition analysis indicated that outgrowth of
peripheral protrusions in epithelial cysts cannot be explained by
simple stabilization of cortical F-actin caused by inhibition of either
myosin-II-dependent cortical flow or depolymerization of actin
Fig. 10. Blebbistatin treatment triggers the reorientation of cortical
microtubules. (A) Caco-2 cells growing on Matrigel-coated coverslips were
treated for 12 hours with either blebbistatin (100 µM) or vehicle, fixed, and
double-labeled for F-actin (green) and α-tubulin (red). In vehicle-treated cells,
cortical microtubules are positioned in parallel to the cell surface behind thick
actomyosin bundles (arrows). Blebbistatin treatment induces the disassembly
of actomyosin bundles and reorientation of cortical microtubules so that they
are perpendicular to the edge of epithelial colonies (arrowheads). Scale bar: 20
µm. (B) Quantification of changes in microtubule distribution. The average
pixel intensity ratios were calculated for α-tubulin signal at the front versus the
back of F-actin cables in control Caco-2 colonies and in the distal versus
proximal parts of peripheral protrusions in blebbistatin-treated colonies. The
pixel intensity ratio was significantly higher in blebbistatin-treated cells, thus
indicating the accumulation of microtubules in close vicinity to the plasma
membrane (*P<0.05).
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filaments (Fig. 3B). These findings raise the possibility that
inhibition of myosin II activates intracellular signaling events that
promote directional actin polymerization at the cyst surface.
Rho GTPases such as Rac1 and Cdc42 represent obvious
candidate signaling molecules that could regulate the generation of
F-actin-rich epithelial spikes. Indeed, these spikes morphologically
resemble filopodia, which are formed at the leading edge of
migrating cells or neurite extensions in growing neurons. Filopodial
formation is known to be Cdc42-dependent (Nobes and Hall, 1995),
and both Cdc42 and Rac1 have been shown to be positive regulators
of neurite outgrowth (Govek et al., 2005). Furthermore, a recent
study revealed the activation of Rac1 in fibroblasts after inhibition
of myosin II activity with blebbistatin or expressional
downregulation of NMMIIA (Even-Ram et al., 2007). Surprisingly,
our experimental data argue against the roles of Rac1 and Cdc42
in the formation of cell surface protrusions following inhibition of
myosin II with blebbistatin. Neither pharmacological inhibitors of
these small GTPases nor expression of their dominant-negative
mutants abrogated blebbistatin-induced protrusions in 3D Caco-2
cysts or in their corresponding 2D colonies (Fig. 4A,B).
Furthermore, blebbistatin treatment failed to increase levels of
activated Rac1 and Cdc42 in Caco-2 cells (Fig. 4C). These findings
are consistent with our observation that the formation of blebbistatin-
induced spikes in SK-CO15 cells does not depend on the activity
of N-WASP and WAVE1 (data not shown), which are downstream
effectors of Cdc42 and Rac1 signaling (Millard et al., 2004;
Takenawa and Suetsugu, 2007). These data, together with the study
in fibroblasts, indicate that the formation of peripheral protrusions
triggered by myosin II inhibition can be mediated via multiple cell-
specific mechanisms.
In a search for alternative intracellular signals that could
contribute to the formation of peripheral F-actin-rich protrusions
following myosin II inhibition in intestinal epithelial cysts, we
demonstrated a role of PLC. Supporting evidence includes
attenuation of spike formation by pharmacological PLC inhibitors
(Fig. 5; supplementary material Fig. S2) and by dual siRNA-
mediated knockdown of PLCγ1/β2 isoforms (Fig. 6), localization
of total and active PLCγ1 in blebbistatin-induced cell surface
protrusions (Fig. 7A), and membrane translocation of PLCγ1 upon
myosin II inhibition (Fig. 7B). Our data are consistent with the
known morphogenic roles of PLC, which has been previously
implicated in neurite outgrowth (Hall et al., 1996; Xie et al., 2006)
and in growth-factor-induced formation of epithelial (Gual et al.,
2000) and endothelial (Meyer et al., 2003) tubules.
How can PLC signaling be involved in the development of
F-actin-rich protrusions? PLC is known to hydrolyze
phosphatidylinositol (4,5)-bisphosphate [PtdIns(4,5)P2], leading to
the generation of inositol (1,4,5)-trisphosphate [Ins(1,4,5)P3] and
diacylglycerol (Lee and Rhee, 1995). All of these lipid mediators
are potent regulators of F-actin dynamics. For example,
PtdIns(4,5)P2 directly interacts with and modulates the activity of
a number of actin-binding proteins, including ADF/cofilin, profilin,
gelsolin, villin and α-actinin (Yin and Janmey, 2003). Ins(1,4,5)P3
triggers Ca2+ release from intracellular stores and thus can activate
Ca2+-dependent regulators of the actin cytoskeleton, whereas
diacylglycerol affects actin dynamics by activating protein kinase
C (Larsson, 2006). Our results suggest that one of these downstream
effectors of PLC mediates the outgrowth of peripheral F-actin-rich
protrusions in myosin-II-inhibited epithelial cysts. Indeed, we
demonstrated that the formation of surface spikes can be inhibited
by overexpression of the inactive cofilin mutant (Fig. 8), whereas
expression of the constitutively active cofilin mutant was sufficient
to stimulate formation of F-actin-rich processes at the cyst surface
even without inhibition of myosin II (Fig. 8C). ADF and cofilin
are known F-actin-severing proteins (Bamburg, 1999; Ono, 2007),
and severing of actin filaments was shown to create free barbed
ends, thus promoting filamentous outgrowth (Cramer, 1999; Wang
et al., 2007). Our results implicating PLC and cofilin in the
development of F-actin-rich surface protrusions are in agreement
with previous findings that PLC positively regulates the severing
of actin filaments by stimulating ADF/cofilin activity (Lee and Rhee,
1995). Such PLC-dependent activation of ADF/cofilin appears to
be a crucial driving force for actin polymerization at the leading
edge of migrating epithelial and fibroblastic cells (Mouneimne et
al., 2006; Mouneimne et al., 2004; Wang et al., 2007). Furthermore,
overexpression of ADF (Meberg and Bamburg, 2000) was shown
to enhance the outgrowth of peripheral protrusions in primary
neurons and neuroendocrine cells, whereas siRNA-mediated
knockdown of cofilin or ADF dramatically abrogated neurite
extension (Endo et al., 2007).
The mechanism whereby inhibition of myosin II activates PLC
signaling remains to be elucidated. Although the major mechanism
of PLCγ1 activation involves its tyrosine and serine phosphorylation
(Bourguignon et al., 2004; Dittmar et al., 2002; Kim et al., 1991),
such activation modes are unlikely to be responsible for the
formation of epithelial protrusions. Indeed, the level of PLCγ1 that
was phosphorylated at Tyr783 and Ser1248/1249 was not increased
in blebbistatin-treated cells, nor did inhibition of tyrosine kinases
prevent spike formation (data not shown). Our data suggest an
alternative mechanism regulating PLC activity in blebbistatin-
treated cysts; this mechanism might involve translocation of PLCγ1
to the plasma membrane (Fig. 7).
PLC-dependent activation of ADF/cofilin alone is unlikely to be
sufficient in inducing surface protrusions in epithelial cysts. In
particular, cofilin activation does not result in directional outgrowth
of radial F-actin-rich protrusions but rather induces the formation
of F-actin blebs at a cyst surface (Fig. 8C). Directionality of spike
outgrowth could be determined by other cytoskeletal structures, and
our data suggest a crucial role for microtubules in this process.
Indeed, the development of peripheral protrusions caused by either
pharmacological or siRNA-mediated inhibition of myosin II was
dramatically attenuated after depolymerization of microtubules (Fig.
9A; supplementary material Figs S2 and S3). Furthermore, these
spikes contained a core of thick microtubule bundles with F-actin
concentrated on their tips (Fig. 9B). The involvement of
microtubules appears to be a common mechanism for the
development of peripheral protrusions observed in growth cones
of migrating neurons (Gordon-Weeks, 2004) as well as in fibroblasts
challenged by growth factors and myosin II inhibitors (Rhee et al.,
2007; Scaife et al., 2003).
The observed interplay between F-actin and microtubules during
the generation of epithelial spikes raises two major questions: how
might myosin II inhibition affect the structure and/or dynamics of
cortical microtubules, and how might changes in microtubule
organization trigger polymerization of F-actin? Our double-
fluorescence labeling analysis revealed that blebbistatin treatment
induces the disassembly of peripheral F-actin bundles, which leads
to the reorientation of cortical microtubules and to their extension
into the submembranous compartment (Fig. 10). Interestingly, a
similar accumulation of microtubules in close proximity to the
plasma membrane has been previously reported in neuronal growth
cones (Zhou et al., 2002) and fibroblast lamellipodia (Even-Ram
Journal of Cell Science 121 (11)
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et al., 2007) after disassembly of F-actin bundles by exposure to
cytochalasin D and blebbistatin, respectively. In addition to the
reorientation of cortical microtubules, blebbistatin also causes a
noticeable bundling (Fig. 10A) and increase in stability of
microtubules in Caco-2 cells (supplementary material Fig. S4).
These results are consistent with recent live-cell imaging analyses
demonstrating a significant decrease in the turnover (extension and
shrinkage) of cortical microtubules in fibroblasts and epithelial cells
after pharmacological inhibition of either myosin II itself (Even-
Ram et al., 2007) or its activator, myosin light chain kinase (Yvon
et al., 2001). Taken together, these data suggest that loss of cortical
actin filaments following myosin II inhibition dramatically affects
the spatial distribution of microtubules, leading to their outgrowth
to the submembranous compartment and initiation of peripheral
protrusions.
Some steps in the signaling cascade controlling microtubule-
dependent actin polymerization remain poorly understood. Two
different mechanisms underlying microtubule-dependent growth of
actin filaments have been described. The first involves activation
of actin-polymerizing proteins, formins, at the dynamic microtubule
tip (Martin et al., 2005). The second implicates the activation of
Rac by growing microtubules (Waterman-Storer et al., 1999).
However, the first mechanism has been described in yeast and has
not been proved in mammalian cells, whereas the second mechanism
cannot explain Rac-independent formation of peripheral protrusions
in blebbistatin-treated epithelial cells (Fig. 4). The observed role
of PLC in cell surface spike formation might provide yet another
mechanism linking cortical microtubules and actin polymerization.
Indeed, PLCγ1 is known to physically interact with a major
microtubule component, β-tubulin (Chang et al., 2005; Itoh et al.,
1996), and such an interaction has been shown to stimulate PLC
activity (Chang et al., 2005). In addition, another study observed
an interaction of PLCγ1 with the microtubule motors kinesins and
suggested microtubule-dependent translocation of cytoplasmic
PLCγ1 to the plasma membrane (Ramoni et al., 2001). Similar
events can be envisioned in myosin-II-inhibited epithelial cells, in
which the reorganization of cortical microtubules might increase
the level and/or activity of PLC at the plasma membrane, thereby
stimulating actin polymerization on microtubule tips and the
formation of surface protrusions.
In conclusion, we propose a hypothetical mechanism that drives
the formation of peripheral spikes after inhibition of myosin II in
intestinal epithelial cells (Fig. 11). Upon myosin II inhibition, loss
of cortical actomyosin bundles leads to the reorientation and/or
stabilization of underlying microtubules and their outgrowth into
the submembranous compartment. This microtubule outgrowth
increases PLC activity at the plasma membrane by either
transporting these enzymes from the cytoplasm or by stimulating
the activity of resident PLC at the plasma membrane. Activation
of PLC stimulates the actin-severing activity of ADF/cofilin,
causing a local increase in free actin-filament barbed ends near the
interface of microtubule tips and the plasma membrane. This event
triggers actin polymerization at microtubule tips leading to the
outgrowth of peripheral protrusions. The described mechanism
might be important for epithelial morphogenesis in vivo, in which
normal activity of myosin II is likely to suppress excessive
protrusiveness of the surface of epithelial cysts, thus preventing
unregulated alterations in cell shape. By contrast, local inhibition
of myosin II by paracrine or cell-bound morphogenic factors might
trigger the development of membrane extensions and regulated
alterations of cell shape, which are both necessary for initial
transformation between the cyst and the tubule as well as later for
tubule branching. Further studies are required to validate this role
of myosin II in epithelial morphogenesis in vivo.
Materials and Methods
Antibodies and other reagents
The following primary polyclonal (pAb) and monoclonal (mAb) antibodies were used
to detect cytoskeletal proteins by immunofluorescence labeling and western blotting:
anti-Cdc42, -PLCγ1, -PLCβ2 pAbs (sc-87, sc-426 and sc-206, respectively; Santa
Cruz Biotechnology, Santa Cruz, CA); anti-Rac1 mAb (ARC03; Cytoskeleton); anti-
phospho-PLCγ1 (Tyr783) pAb (#2821; Cell Signaling Technology, Danver, MA);
phospho-PLCγ1 (Ser1248/1249) pAb (#07-511; Upstate, Charlottesville, VA); anti-
mammalian nonmuscle myosin IIA and IIB pAbs (PRB-440P and PRB-445P,
respectively; Covance, Berkley, CA); anti-α-tubulin mAb (#T6199; Sigma-Aldrich,
St Louis, MO). Alexa-Fluor-488-labeled phalloidin and secondary antibodies were
obtained from Molecular Probes (Eugene, OR); horseradish-peroxidase-conjugated
secondary antibodies were obtained from Jackson ImmunoResearch Laboratories
(West Grove, PA).
Rac and/or Cdc42 activation assay kits were purchased from Upstate. Secramine
A was provided by Tomas Kirchhausen, Matthew D. Shair, Henry E. Pelish (Harvard
Medical School, Boston, MA) and Gerald B. Hammond (University of Louisville,
KY) (Xu et al., 2006). NSC23766 was provided by Yi Zheng (Children Hospital
Research Foundation, Cincinnati, OH). S(–)-blebbistatin, Y27632, jasplakinolide,
wiskostatin, SP 600125, U0126, ERKII inhibitor, PD 98059, LY 294002 and
Herbimycin A were obtained from Calbiochem (La Jolla, CA); U23122, vinblastin,
nocodazole, genistein and WGA were obtained from Sigma. ET-18-OCH3 was
purchased from Biomol.
3D epithelial cell culture
Caco-2 (American Type Culture Collection, Manassas, VA) and SK-CO15 (gift of
Enrique Rodriguez-Boulan, Weill Medical College of Cornell University, NY)
human colonic epithelial cell lines were cultured in high glucose Dulbecco’s minimal
essential medium (DMEM) supplemented with 15 mM HEPES, 40 µg/ml penicillin,
100 µg/ml streptomycin and 10% fetal bovine serum (pH 7.4). Cells were resuspended
in DMEM medium and mixed with growth-factor-reduced Matrigel (BD Biosciences,
Franklin Lakes, NJ). For each experiment, approximately 106 cells were embedded
into 200 µl of 30-35% Matrigel. A 3D matrix was allowed to harden in a 96-well
Fig. 11. Hypothetic mechanism for surface protrusion formation in myosin-II-
inhibited intestinal epithelial cysts. The diagram depicts key signaling and
morphological events involved in the development of peripheral spikes. For
simplicity, these events are presented as a single cascade. Tentative and/or
unproven connections between different steps in the cascade are marked by
broken lines. See explanation in the Discussion.
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plate at 37°C for 30 minutes, then DMEM medium was added and cysts were allowed
to form over 3-4 days at 37°C. Pharmacological inhibitors were added to the medium
at concentrations indicated in the Results and figure legends. Stock solutions of water-
insoluble inhibitors were prepared in DMSO and diluted in cell culture media
immediately before each experiment. The final concentration of DMSO was 0.1%
and was included in appropriate controls.
2D cell culture
Caco-2 cells were plated onto 12-mm glass coverslips coated with a thin layer of
30% Matrigel. Cells were allowed to grow for 3-4 days at 37°C before challenging
with pharmacological agents or infecting with adenoviruses. Adenoviruses expressing
EGFP-tagged dominant-negative mutants N17Rac1 and N17Cdc42, a constitutively
inactive S3E mutant of Xenopus cofilin as well as control EGFP virus were provided
by James Bamburg (University of Colorado, CO) and were produced as described
previously (Minamide et al., 2003; Suurna et al., 2006). Cells were incubated in
DMEM containing purified viral particles diluted to 53105 plaque-forming units/ml
for 2-3 days before treatment with blebbistatin.
Immunofluorescence labeling and confocal microscopy
Caco-2 cells growing on coverslips were fixed with either absolute ethanol or 4%
paraformaldehyde and fluorescently labeled as previously described (Ivanov et al.,
2005; Ivanov et al., 2006). For visualization of F-actin and myosin II in 3D cultures,
Matrigel fragments were fixed for 1 hour in 4% paraformaldehyde, permeabilized
for 30 minutes with 0.5% TX-100, blocked overnight with 3% bovine serum albumin
at 4°C, incubated for 2 hours at room temperature with primary anti-myosin II
antibodies followed by 2 hours of incubation with Alexa-Fluor-488-conjugated
phalloidin and secondary antibodies, and mounted with a 1:1:0.01 (v/v/v)
PBS/glycerol/p-phenylenediamine mixture. Labeled cells were examined using a
Zeiss LSM510 Meta laser scanning confocal microscope (Zeiss Microimaging,
Thornwood, NY). Fluorescent dyes were imaged sequentially in frame-interlace mode
to eliminate fluorescence bleed-over between channels. Images were processed using
LSM5 browser software and Adobe Photoshop. For the 3D system, images
demonstrate a single confocal section acquired at the center of the cyst. Cysts
possessing spikes were counted across at least ten different 403 fields and expressed
as a percentage of total cysts. At least 70 cysts were examined per experimental
group.
Immunoblotting
Cells were homogenized in a RIPA lysis buffer (20 mM Tris, 50 mM NaCl, 2 mM
EDTA, 2 mM EGTA, 1% sodium deoxycholate, 1% TX-100 and 0.1% SDS, pH 7.4)
containing proteinase- and phosphatase-inhibitor cocktails (Sigma). Polyacrylamide
gel electrophoresis and western blotting were conducted by standard protocols with
10-20 µg protein per lane. Results shown are representative immunoblots of three
independent experiments. Protein expression was quantified by densitometric analysis
of western blot images on UN-SCAN-IT digitizing software (Silk Scientific, Orem,
UT).
Rac and Cdc42 activation assay
Activation status of Rac1 and Cdc42 was determined using commercially available
activation assays according to the manufacturer protocols. Briefly, cell lysates were
cleared by centrifugation (14,000 g for 15 minutes) and supernatants were incubated
with recombinant PAK1-GST coupled to agarose beads (45 minutes, 4°C with
rotation). Beads were washed and resuspended in SDS sample buffer for western
blot analysis using anti-Rac1 and anti-Cdc42 antibodies. Whole-cell lysates prepared
in the same experiment were also subjected to immunoblotting to show levels of total
(active plus inactive) Rac1 and Cdc42.
Membrane preparation
Cells were harvested in relax buffer (100 mM KCl, 3 mM NaCl, 3.5 mM MgCl2, 10
mM HEPES, pH 7.4) containing protease- and phosphatase-inhibitor cocktails, and
was nitrogen-cavitated (200 psi, 15 minutes). Nuclei were removed by centrifugation
(1000 g for 10 minutes). Membranes were pelleted by ultracentrifugation of the post-
nuclear supernatants at 170,000 g for 45 minutes. Supernatants (cytosolic fraction)
were collected and the pellets were resuspended in an equivalent volume (equivalent
to the starting volume of cell lysate) of Hanks balanced salt solution (HBSS+)
containing 1% n-octylglucoside by sonication on ice. Equal volumes of the cytosolic
and membrane fractions were subjected to immunoblotting analysis as described
above.
Microtubule fractionation
Relative amounts of stable and unstable microtubules in control and blebbistatin-
treated cells were determined using detergent fractionation of the cells. Caco-2 colonies
growing on Matrigel were washed with HBSS+ and were gently rotated for 5 minutes
at room temperature with extraction buffer (80 mM Pipes, 1 mM MgCl2, 2 mM EGTA,
0.15% TX-100, pH 6.9) supplemented with proteinase- and phosphatase-inhibitor
cocktails (Sigma). The extraction solution was removed, mixed with an equal volume
of 2X-SDS sample buffer and boiled. The TX-100-insoluble fraction was collected
by scraping pre-extracted, filter-bound cells in two volumes of 1X-SDS sample buffer
with subsequent homogenizing and boiling. The amount of α-tubulin in each fraction
was determined by electrophoresis and western blotting.
RNA interference
siRNA-mediated knockdown of NMMIIA was carried out using three isoform-
specific siRNA duplexes: 59-GCACAGAGCUGGCCGACAAUU-39; 59-GGC-
CAAACCUGCCGAAUAAUU-39 and 59-GAACAUGGCCCUCAAGAAGUU-39
(Dharmacon, Lafayette, CO). Downregulation of PLCγ1, PLCβ2, N-WASP and
WAVE1 expression was performed using protein-specific siRNA SmartPools
(Dharmacon). Cyclophilin B siRNA SmartPool was used as a control. SK-CO15 cells
were transfected using the DharmaFect 1 transfection reagent (Dharmacon) in Opti-
MEM I medium (Invitrogen), according to the manufacturer’s protocol, with a final
siRNA concentration of 100 nM. Cells on six-well plates were transfected with siRNA,
embedded into Matrigel 12 hours later and allowed to form cysts for an additional 72
hours.
Statistics
Numerical values from three different experiments were pooled and expressed as
mean ± s.e.m. throughout. Obtained numbers were compared by a single-tailed
Student’s t-test, with statistical significance assumed at P<0.05.
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